Giant Cell Arteritis

Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia
Kornelis S M van der Geest, Frances Borg, Abdul Kayani, Davy Paap, Prisca Gondo, Wolfgang Schmidt, Raashid Ahmed Luqmani, Bhaskar Dasgupta

Annals of the Rheumatic Diseases Jan 2020, annrheumdis-2019-216343; DOI: 10.1136/annrheumdis-2019-216343
2018 Update of the EULAR recommendations for the management of large vessel vasculitis
Bernhard Hellmich, Ana Agueda, Sara Monti, Frank Buttgereit, Hubert de Boysson, Elisabeth Brouwer, Rebecca Cassie, Maria C Cid, Bhaskar Dasgupta, Christian Dejaco, Gulen Hatemi, Nicole Hollinger, Alfred Mahr, Susan P Mollan, Chetan Mukhtyar, Cristina Ponte, Carlo Salvarani, Rajappa Sivakumar, Xinping Tian, Gunnar Tomasson, Carl Turesson, Wolfgang Schmidt, Peter M Villiger, Richard Watts, Chris Young, Raashid Ahmed Luqmani

Annals of the Rheumatic Diseases Jan 2020, 79 (1) 19-30; DOI: 10.1136/annrheumdis-2019-215672
Response to: ‘Correspondence to ‘Slope sign’: a feature of large vessel vasculitis?’ by Milchert et al
Alwin Sebastian, Abdul Kayani, Bhaskar Dasgupta

Annals of the Rheumatic Diseases Dec 2019, annrheumdis-2019-216690; DOI: 10.1136/annrheumdis-2019-216690
Retinal vasculometric characteristics and their associations with polymyalgia rheumatica and giant cell arteritis in a prospective cohort: EPIC-Norfolk Eye Study
Max Yates, Roshan Welikala, Alicja Rudnicka, Tunde Peto, Alexander J MacGregor, Anthony Khawaja, Richard Watts, David Broadway, Shabina Hayat, Robert Luben, Sarah Barman, Christopher Owen, Kay-Tee Khaw, Paul Foster

Annals of the Rheumatic Diseases Nov 2019, annrheumdis-2019-216078; DOI: 10.1136/annrheumdis-2019-216078
Correspondence to ‘Slope sign’: a feature of large vessel vasculitis?
Marcin Milchert, Marek Brzosko, Anne Bull Haaversen, Andreas P Diamantopoulos

Annals of the Rheumatic Diseases Nov 2019, annrheumdis-2019-216601; DOI: 10.1136/annrheumdis-2019-216601
‘Slope sign’: a feature of large vessel vasculitis?
Bhaskar Dasgupta, Kate Smith, Abdullah Abu Syeed Khan, Fiona Coath, Richard J Wakefield

Annals of the Rheumatic Diseases Dec 2019, 78 (12) 1738; DOI: 10.1136/annrheumdis-2019-216213
Temporal ultrasound for monitoring tocilizumab treatment in giant cell arteritis: seeing beyond serum markers?
Gerasimos Evangelatos, George E Fragoulis, Alexios Iliopoulos

Annals of the Rheumatic Diseases Nov 2019, annrheumdis-2019-216527; DOI: 10.1136/annrheumdis-2019-216527
Clinical symptoms and associated vascular imaging findings in Takayasu’s arteritis compared to giant cell arteritis
Despina Michailidou, Joel S Rosenblum, Casey A Rimland, Jamie Marko, Mark A Ahlman, Peter C Grayson

Annals of the Rheumatic Diseases Oct 2019, annrheumdis-2019-216145; DOI: 10.1136/annrheumdis-2019-216145
Remission maintenance after tocilizumab dose-tapering and interruption in patients with giant cell arteritis: an open-label, 18-month, prospective, pilot study
Carlotta Nannini, Laura Niccoli, Stelvio Sestini, Iashar Laghai, Angela Coppola, Fabrizio Cantini

Annals of the Rheumatic Diseases Oct 2019, 78 (10) 1444-1446; DOI: 10.1136/annrheumdis-2019-215585
Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses
Christoph T Berger, Birke Rebholz-Chaves, Mike Recher, Tobias Manigold, Thomas Daikeler

Annals of the Rheumatic Diseases Jul 2019, 78 (7) 1012-1014; DOI: 10.1136/annrheumdis-2018-214704

Main menu

Giant Cell Arteritis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Giant Cell Arteritis

Pages